Generics - North America, Asia-Pacific


Current filters:

North AmericaAsia-Pacific

Popular Filters

No changes in Australian domestic IP warranted, say generic drugmakers

No changes in Australian domestic IP warranted, say generic drugmakers


Members of the generic drugs industry are calling on the Australian government to support efforts to…

Asia-PacificGenericsNorth AmericaPatentsPolitics

MSF warns of US/Indian tension over generic policy discussion

MSF warns of US/Indian tension over generic policy discussion


Humanitarian group Médecins Sans Frontières has warned that India is facing political pressure from…

Anti-viralsAsia-PacificBayerGenericsGleevecHealthcareNexavarNorth AmericaNovartisPolitics

Ban on FDA-regulated drugs from Ranbaxy's Mohali plant


There was another blow for India's largest drugmaker Ranbaxy Laboratories (BSE: 500359) yesterday (September…

Asia-PacificDaiichi SankyoGenericsNorth AmericaProductionRanbaxy LaboratoriesRegulation

Intas Pharma settles with Roche over Xeloda; Merck & Co wins injunction against Aprica


Indian drugmaker Intas Pharmaceuticals and its wholly owned subsidiary Accord Healthcare have entered…

Aprica PharmaceuticalsAsia-PacificDiabetesGenericsIntas PharmaceuticalsMerck & CoNorth AmericaOncologyPatentsRocheXeloda

US DoJ says Ranbaxy pleads guilty and agrees to pay $500 million in settlements


In the largest drug safety settlement to date with a generic drug manufacturer, Ranbaxy USA, a subsidiary…

Asia-PacificDaiichi SankyoFinancialGenericsLegalNorth AmericaProductionRanbaxy LaboratoriesRegulation

Canada's Pharmascience sets up JV with Korea Kolmar; buys Rivex


Privately-held Canadian drugmaker Pharmascience and Korea Kolmar Holdings, based in Seoul, South Korea,…

Asia-PacificBiotechnologyGenericsHelix BioPharmaKorea KolmarMergers & AcquisitionsNeurologicalNorth AmericaPharmaceuticalPharmascienceRivex Pharma

PhRMA disputes Indian claims relating to cancer drug shortages


In a recent interview with Times of India, a trade association that represents several major generic…

Asia-PacificGenericsNorth AmericaPatentsPharmaceuticalPolitics

Breckenridge in generic Viramune deal with Zhejiang Huahai Pharma


Privately-held US generic drugmaker Breckenridge Pharmaceutical that it has finalized its agreement with…

Anti-viralsAsia-PacificBoehringer IngelheimBreckenridge PharmaceuticalsGenericsMarkets & MarketingNevirapineNorth AmericaPatentsViramuneZhejiang Huahai Pharma

Sigma-Aldrich acquires Research Organics; opens new facility in China


USA-headquartered Sigma-Aldrich (Nasdaq: SIAL) has acquired all outstanding shares of Cleveland, Ohio-based,…

Asia-PacificGenericsMarkets & MarketingMergers & AcquisitionsNorth AmericaPharmaceuticalResearch OrganicsSigma-Aldrich

Frontage and Fanghui Pharma launch $10 million collaboration


Emerging Chinese pharmaceutical company Luohe Fanghui Pharmaceutical has launched a new globalization…

Asia-PacificFanghui PharmaceuticalsFinancialFrontage LaboratoriesGenericsNorth AmericaRegulation

Back to top